Shukra Pharmaceuticals to Set Up INR 587 Cr Medical Devices Manufacturing Facility in UP

A key highlight of Shukra Pharmaceuticals’ proposed facility will be the domestic manufacturing of Boron Neutron Capture Therapy, regarded as one of the most advanced treatment options for complex cancer cases.

Shukra Pharmaceuticals has received a Letter of Intent from the Yamuna Expressway Industrial Development Authority (YEIDA) to set up an INR 587 Cr medical devices manufacturing facility in Uttar Pradesh, for a 10-acre plot in the Medical Devices Park under the Invest UP initiative.

The proposed facility has been positioned as a high-technology manufacturing hub aimed at producing world-class, affordable medical devices for India and export markets. The project forms part of Uttar Pradesh’s broader effort to build a robust med-tech ecosystem under the state’s ‘Make in UP’ and national ‘Aatmanirbhar Bharat’ initiatives.

The Medical Devices Park, located along the Yamuna Expressway in Sector 28, has been developed as one of India’s largest dedicated clusters for medical device manufacturing. Spread across more than 350 acres, the park has already attracted strong industry interest, with land allotted to over 100 companies and investment commitments exceeding INR 1,200 Cr.

A key highlight of Shukra Pharmaceuticals’ proposed facility will be the domestic manufacturing of Boron Neutron Capture Therapy, regarded as one of the most advanced treatment options for complex cancer cases.

Until now, access to this technology has largely depended on foreign suppliers. Indigenous production is expected to improve availability, lower costs, and support the wider adoption of advanced cancer treatment in India.

Beyond oncology, the facility will manufacture a wide range of cardiology medical devices, including heart valves, stents and Left Ventricular Assist Devices, which are critical for patients with severe cardiac conditions.

In the radiology and imaging segment, the unit plans to produce CT scanners, MRI systems, PET scanners, X-ray machines and ultrasound devices, addressing the growing demand for diagnostic infrastructure across healthcare facilities.

The project will also cover anaesthesia systems, ventilators and oxygen concentrators, strengthening critical and respiratory care capabilities. Another major focus area will be medical robotics and AI-enabled surgical systems. These include soft-tissue surgical robots, orthopaedic and dental robotic systems, as well as advanced neuro-spine robotic platforms designed to enhance surgical precision and outcomes.

In-vitro diagnostic solutions, including point-of-care testing devices and advanced analysers, will also be manufactured to support faster and more accurate diagnosis. Medical simulators for training doctors, nurses and paramedical staff are planned as part of the facility, contributing to skill development and patient safety.

Stay tuned for more such updates on Digital Health News